v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Cash flows from operating activities:          
Net loss $ (15,819,657) $ (22,505,824) $ (53,262,775) $ (37,370,107)  
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:          
Depreciation and amortization     437,579 524,206  
Amortization of operating lease assets     345,761 343,521  
Stock-based compensation expense     4,759,765 1,515,274  
Net gain on digital assets     (4,153,223) (732,410)  
Investments in affiliates gain     (87,211) (38,891)  
Non-cash interest expense     161,285    
Impairment of failed acquisition 500,000   500,000    
Change in deferred income taxes       (4,403,068)  
Change in operating assets and liabilities:          
Accounts receivable     (4,677,116) 16,539,539  
Physical media inventory     237,196 (279,532)  
Prepaid expenses and other current assets     (622,039) (990,694)  
Licensing receivables     4,062,976 (5,862,011)  
Other long-term assets       (15,000)  
Accounts payable and accrued expenses     6,910,533 2,082,526  
Accrued licensing royalties     3,080,204 (3,918,106)  
Operating lease liabilities     (330,670) (325,368)  
Deferred revenue     17,938,955 3,768,831  
Net cash and cash equivalents used in operating activities     (24,698,780) (29,161,290)  
Cash flows from investing activities:          
Purchases of property and equipment     (118,942) (244,581)  
Issuance of notes receivable     (974,176) (1,352,311)  
Collections of notes receivable     440,643 1,688,769  
Purchase of digital assets       (48,515)  
Sale of digital assets     99,118 964,178  
Purchase of content     (4,274,150) (317,747)  
Investments in affiliates     (2,982,032) 39,458  
Net cash and cash equivalents provided by (used in) investing activities     (7,809,539) 729,251  
Cash flows from financing activities:          
Repayment of notes payable     (24,338,861) (15,660,616)  
Repayment of loan guarantee     (6,000,000)    
Receipt of notes payable     48,891,000 15,043,019  
Repayment of accrued settlement costs     (136,660) (123,807)  
Exercise of stock options     190,733 224,167  
Issuance of common stock     38,503,670 8,249,971 $ 32,800,000
Contribution of equity in noncontrolling interests     8,731,422    
Redemption of equity in noncontrolling interests     (11,750,000)    
Fees related to issuance of common stock and minority interest     (398,660)    
Repurchase of common stock     (132,940) (113,894)  
Debt financing fees     (263,532)    
Net cash and cash equivalents provided by financing activities     53,296,172 7,618,840  
Effect of changes in foreign currency exchange rates on cash and cash equivalents       (2,063)  
Net increase (decrease) in cash and cash equivalents     20,787,853 (20,815,262)  
Cash and cash equivalents at beginning of period     7,211,826 25,201,425 25,201,425
Cash and cash equivalents at end of period $ 27,999,679 $ 4,386,163 27,999,679 4,386,163 $ 7,211,826
Supplemental disclosure of cash flow information:          
Cash paid for interest     2,624,497 949,124  
Supplemental schedule of noncash financing activities:          
Adoption of ASU No. 2023-08     15,962,018    
Change from digital assets to digital assets receivable     21,748,336    
Operating lease right-of-use assets and liabilities     $ 145,980 $ 2,137,262